Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment

Table 6

The information of the first 20 biological processes enriched by downregulated CXCR2-relevant genes.

Description	GeneRatio	BgRatio	value	FDR	Size
Forebrain regionalization	2/18	24/18866	0.000234	0.105833	2
Triglyceride catabolic process	2/18	38/18866	0.000592	0.105833	2
Regulation of gastrulation	2/18	43/18866	0.000759	0.105833	2
Neutral lipid catabolic process	2/18	48/18866	0.000945	0.105833	2
Acylglycerol catabolic process	2/18	48/18866	0.000945	0.105833	2
Regulation of sodium ion transmembrane transporter activity	2/18	55/18866	0.001239	0.110357	2
Regulation of sodium ion transmembrane transport	2/18	65/18866	0.001726	0.110357	2
Neural retina development	2/18	72/18866	0.002112	0.110357	2
Regulation of cardiac conduction	2/18	73/18866	0.002171	0.110357	2
Glycerolipid catabolic process	2/18	74/18866	0.00223	0.110357	2
Regulation of sodium ion transport	2/18	88/18866	0.003135	0.110357	2
Axis specification	2/18	88/18866	0.003135	0.110357	2
Regulation of neural precursor cell proliferation	2/18	91/18866	0.003348	0.110357	2
Dorsal/ventral pattern formation	2/18	92/18866	0.003421	0.110357	2
Triglyceride metabolic process	2/18	110/18866	0.004849	0.110357	2
Endocrine system development	2/18	125/18866	0.006216	0.110357	2
Camera-type eye morphogenesis	2/18	125/18866	0.006216	0.110357	2
Regulation of embryonic development	2/18	134/18866	0.007111	0.110357	2
Neutral lipid metabolic process	2/18	138/18866	0.007527	0.110357	2
Acylglycerol metabolic process	2/18	138/18866	0.007527	0.110357	2